{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:42:48Z","timestamp":1794469368356,"version":"4.9.1"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2023AH050682"],"award-info":[{"award-number":["2023AH050682"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2021xkjT025"],"award-info":[{"award-number":["2021xkjT025"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["202310366014"],"award-info":[{"award-number":["202310366014"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.critrevonc.2025.104859","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T23:54:40Z","timestamp":1753142080000},"page":"104859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Metabolic reprogramming of NK cells drives anti-tumor immunity"],"prefix":"10.1016","volume":"215","author":[{"given":"Pengcheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.critrevonc.2025.104859_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cells12182240","article-title":"Myoglobin in brown adipose tissue: a multifaceted player in thermogenesis","volume":"12","author":"Aboouf","year":"2023","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104859_bib2","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1074\/jbc.RA118.005892","article-title":"Interleukin-18 up-regulates amino acid transporters and facilitates am ino acid\u2013induced mTORC1 activation in natural killer cells","volume":"294","author":"Almutairi","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib3","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12935-022-02815-4","article-title":"Rise of the natural red pigment 'prodigiosin' as an immunomodulator in cancer","volume":"22","author":"Anwar","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104859_bib4","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ni.3838","article-title":"Srebp-controlled glucose metabolism is essential for NK cell functiona l responses","volume":"18","author":"Assmann","year":"2017","journal-title":"Nat. Immunol."},{"issue":"48","key":"10.1016\/j.critrevonc.2025.104859_bib5","doi-asserted-by":"crossref","first-page":"18757","DOI":"10.1074\/jbc.TM118.003336","article-title":"Polyamine synthesis as a target of MYC oncogenes","volume":"293","author":"Bachmann","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104859_bib6","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.4049\/jimmunol.2001215","article-title":"Cutting Edge: mTORC1 inhibition in metastatic breast cancer patients negatively affects peripheral NK cell maturation and number","volume":"206","author":"Besson","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104859_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.tips.2023.08.009","article-title":"Metabolic adaptation of NK cell activity and behavior in tumors: challenges and therapeutic opportunities","author":"Borde","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104859_bib8","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of can cer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2025.104859_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-981-33-6785-2_5","article-title":"Lipid metabolism in tumor-associated natural killer cells","volume":"1316","author":"Chen","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104859_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cmet.2018.06.021","article-title":"Dysfunction of natural killer cells by FBP1-induced inhibition of Glyc olysis during lung cancer progression","volume":"28","author":"Cong","year":"2018","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104859_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2016.07.003","article-title":"Acidosis drives the reprogramming of fatty acid metabolism in cancer cells through changes in mitochondrial and histone acetylation","volume":"24","author":"Corbet","year":"2016","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104859_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.2020007748","article-title":"Targeting a cytokine checkpoint enhances the fitness of armored cord b lood CAR-NK cells","volume":"137","author":"Daher","year":"2021","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104859_bib13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2013.01.022","article-title":"Loss of FBP1 by snail-mediated repression provides metabolic advantages in basal-like breast cancer","volume":"23","author":"Dong","year":"2013","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104859_bib14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41590-019-0388-z","article-title":"The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc","volume":"20","author":"Dong","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104859_bib15","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/343268","article-title":"Plasma granzyme B in ST elevation myocardial infarction versus non-ST elevation acute coronary syndrome: comparisons with IL-18 and fractalkine","volume":"2013","author":"El-Mesallamy","year":"2013","journal-title":"Mediat. Inflamm."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbcan.2017.04.002","article-title":"Linking tumor glycolysis and immune evasion in cancer: Emerging concepts and therapeutic opportunities","volume":"1868","author":"Ganapathy-Kanniappan","year":"2017","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104859_bib17","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1038\/onc.2015.381","article-title":"ASCT2\/SLC1A5 controls glutamine uptake and tumour growth in triple-neg ative basal-like breast cancer","volume":"35","author":"van Geldermalsen","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbcan.2019.05.006","article-title":"Gluconeogenesis in cancer cells - Repurposing of a starvation-induced metabolic pathway?","volume":"1872","author":"Grasmann","year":"2019","journal-title":"Biochimica et biophysica acta. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104859_bib19","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1158\/0008-5472.CAN-08-4806","article-title":"Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry","volume":"69","author":"Hirayama","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2025.104859_bib20","doi-asserted-by":"crossref","first-page":"1303605","DOI":"10.3389\/fimmu.2023.1303605","article-title":"NK cell exhaustion in the tumor microenvironment","volume":"14","author":"Jia","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104859_bib21","doi-asserted-by":"crossref","first-page":"1420205","DOI":"10.3389\/fimmu.2024.1420205","article-title":"The basic biology of NK cells and its application in tumor immunotherapy","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-10015-4","article-title":"Competition for nutrients and its role in controlling immune responses","volume":"10","author":"Kedia-Mehta","year":"2019","journal-title":"Nat. Commun."},{"issue":"26","key":"10.1016\/j.critrevonc.2025.104859_bib23","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1182\/blood.2020005602","article-title":"Increased lipid metabolism impairs NK cell function and mediates adapt ation to the lymphoma environment","volume":"136","author":"Kobayashi","year":"2020","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104859_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/14728222.2020.1744568","article-title":"TGF-beta: a master immune regulator","volume":"24","author":"Larson","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104859_bib25","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1038\/s41418-020-00715-6","article-title":"mTORC1 and mTORC2 coordinate early NK cell development by differentially inducing E4BP4 and T-bet","volume":"28","author":"Li","year":"2021","journal-title":"Cell Death Differ."},{"issue":"30","key":"10.1016\/j.critrevonc.2025.104859_bib26","doi-asserted-by":"crossref","first-page":"eadd6997","DOI":"10.1126\/sciadv.add6997","article-title":"Loss of metabolic fitness drives tumor resistance after CAR-NK cell th erapy and can be overcome by cytokine engineering","volume":"9","author":"Li","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.critrevonc.2025.104859_bib27","article-title":"MEF2C regulates NK cell effector functions through control of lipid me tabolism","author":"Li","year":"2024","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/hep.29183","article-title":"A functional mammalian target of rapamycin complex 1 signaling is indi spensable for c-Myc-driven hepatocarcinogenesis","volume":"66","author":"Liu","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2025.104859_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-01014-w","article-title":"NK cell-based cancer immunotherapy: from basic biology to clinical development","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104859_bib30","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrc3557","article-title":"Serine, glycine and one-carbon units: cancer metabolism in full circle","volume":"13","author":"Locasale","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib31","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","article-title":"CAR-cell therapy in the era of solid tumor treatment: current challeng es and emerging therapeutic advances","volume":"22","author":"Maalej","year":"2023","journal-title":"Mol. Cancer"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104859_bib33","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI45816","article-title":"Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity","volume":"121","author":"Mamessier","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104859_bib34","first-page":"1475","article-title":"IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells","volume":"128","author":"Mao","year":"2016","journal-title":"Blood J. Am. Soc. Hematol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104859_bib35","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/ni.2936","article-title":"The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells","volume":"15","author":"Mar\u00e7ais","year":"2014","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104859_bib36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1083\/jcb.201604085","article-title":"The importance of serine metabolism in cancer","volume":"214","author":"Mattaini","year":"2016","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/s12967-024-05033-w","article-title":"Advances in metabolic reprogramming of NK cells in the tumor microenvironment on the impact of NK therapy","volume":"22","author":"Miao","year":"2024","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104859_bib38","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1038\/s41590-018-0251-7","article-title":"Metabolic reprogramming of natural killer cells in obesity limits anti tumor responses","volume":"19","author":"Michelet","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104859_bib39","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiol ogical importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/imr.13316","article-title":"Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment","volume":"323","author":"Moinuddin","year":"2024","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104859_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104859_bib42","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.immuni.2020.05.001","article-title":"Single-cell RNA sequencing of tumor-infiltrating NK cells reveals that inhibition of transcription factor HIF-1\u03b1 unleashes NK cell activity","volume":"52","author":"Ni","year":"2020","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104859_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","article-title":"Bidirectional transport of amino acids regulates mTOR and autophagy","volume":"136","author":"Nicklin","year":"2009","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/eji.202048784","article-title":"De novo polyamine synthesis supports metabolic and functional response s in activated murine NK cells","volume":"51","author":"O'Brien","year":"2021","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104859_bib45","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2025.104859_bib46","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1038\/ncomms11154","article-title":"Repression of GSK3 restores NK cell cytotoxicity in AML patients","volume":"7","author":"Parameswaran","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104859_bib47","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.celrep.2017.04.042","article-title":"mTORC1 Balances cellular amino acid supply with demand for protein syn thesis through post-transcriptional control of ATF4","volume":"19","author":"Park","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib48","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1038\/s41598-021-82706-2","article-title":"MEF2C shapes the microtranscriptome during differentiation of skeletal muscles","volume":"11","author":"Piasecka","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104859_bib49","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1111\/febs.15531","article-title":"A guide to plasma membrane solute carrier proteins","volume":"288","author":"Pizzagalli","year":"2020","journal-title":"FEBS J."},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104859_bib50","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/0008-5472.CAN-10-4179","article-title":"Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma","volume":"71","author":"Platonova","year":"2011","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104859_bib51","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","article-title":"Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment","volume":"33","author":"Poznanski","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.critrevonc.2025.104859_bib52","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3389\/fimmu.2019.01414","article-title":"What defines NK cell functional fate: phenotype or metabolism?","volume":"10","author":"Poznanski","year":"2019","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104859_bib53","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.15252\/embj.201490252","article-title":"Single cell tuning of Myc expression by antigen receptor signal strength and interleukin-2 in T lymphocytes","volume":"34","author":"Preston","year":"2015","journal-title":"Embo J."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104859_bib54","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3233\/CBM-160603","article-title":"Beclin-1 and hypoxia-inducible factor-1\u03b1 genes expression: Potential biomarkers in acute leukemia patients","volume":"16","author":"Radwan","year":"2016","journal-title":"Cancer Biomark."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ijc.32410","article-title":"Therapeutic cooperation between auranofin, a thioredoxin reductase inh ibitor and anti-PD-L1 antibody for treatment of triple-negative breast cancer","volume":"146","author":"Raninga","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104859_bib56","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3389\/fimmu.2020.00311","article-title":"NK cell function regulation by TGF-\u03b2-induced epigenetic mechanisms","volume":"11","author":"Regis","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104859_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004458","article-title":"Targeting of Nrf2 improves antitumoral responses by human NK cells, TIL and CAR T cells during oxidative stress","volume":"10","author":"Renken","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104859_bib58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.diabres.2017.07.013","article-title":"Peripheral leucocytes and tissue gene expression of granzyme B\/perforin system and serpinB9: Impact on inflammation and insulin resistance in coronary atherosclerosis","volume":"131","author":"Sanad","year":"2017","journal-title":"Diabetes Res. Clin. Pr."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104859_bib59","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104859_bib60","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","article-title":"Regulation and metabolic functions of mTORC1 and mTORC2","volume":"101","author":"Szwed","year":"2021","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.critrevonc.2025.104859_bib61","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.3389\/fimmu.2019.02278","article-title":"NK cell metabolism and tumor microenvironment","volume":"10","author":"Terr\u00e9n","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104859_bib62","article-title":"Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation","volume":"35","author":"Truman","year":"2021","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"5930","key":"10.1016\/j.critrevonc.2025.104859_bib63","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell p roliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science (New York N. Y.)"},{"issue":"7599","key":"10.1016\/j.critrevonc.2025.104859_bib64","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nature17442","article-title":"Metabolic maintenance of cell asymmetry following division in activate d T lymphocytes","volume":"532","author":"Verbist","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104859_bib65","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib66","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib67","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","article-title":"The cancer metabolic reprogramming and immune response","volume":"20","author":"Xia","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41388-022-02562-w","article-title":"Metabolic hallmarks of natural killer cells in the tumor microenvironment and implications in cancer immunotherapy","volume":"42","author":"Yang","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2025.104859_bib69","doi-asserted-by":"crossref","first-page":"1061394","DOI":"10.3389\/fimmu.2022.1061394","article-title":"TGF-\u03b2: A novel predictor and target for anti-PD-1\/PD-L1 therapy","volume":"13","author":"Yi","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104859_bib70","doi-asserted-by":"crossref","first-page":"1517959","DOI":"10.3389\/fimmu.2025.1517959","article-title":"Immunocytes in the tumor microenvironment: recent updates and interconnections","volume":"16","author":"Yu","year":"2025","journal-title":"Front Immunol."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104859_bib71","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1016\/j.celrep.2017.12.002","article-title":"Oncogenic MYC activates a feedforward regulatory loop promoting Essent ial amino acid metabolism and tumorigenesis","volume":"21","author":"Yue","year":"2017","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.17691\/stm2025.17.1.10","article-title":"Efficacy evaluation of \"Enhanced\" natural killers with CISH and B2M knockouts on viability and metabolic status of 3D glioblastoma spheroid cells in patients","volume":"17","author":"Yuzhakova","year":"2025","journal-title":"Sovrem. Tekhnologii Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104859_bib73","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1073\/pnas.96.5.2071","article-title":"The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation","volume":"96","author":"Zhang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"21","key":"10.1016\/j.critrevonc.2025.104859_bib74","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1158\/0008-5472.CAN-20-0600","article-title":"5-Fluorouracil enhances the antitumor activity of the glutaminase inhibitor CB-839 against PIK3CA-mutant colorectal cancers","volume":"80","author":"Zhao","year":"2020","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104859_bib75","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/s41590-019-0511-1","article-title":"Mitochondrial fragmentation limits NK cell-based tumor immunosurveillance","volume":"20","author":"Zheng","year":"2019","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104859_bib76","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/s41590-023-01462-9","article-title":"Tumors evade immune cytotoxicity by altering the surface topology of N K cells","volume":"24","author":"Zheng","year":"2023","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104859_bib77","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12943-023-01737-7","article-title":"NK cells are never alone: crosstalk and communication in tumour microe nvironments","volume":"22","author":"Zhou","year":"2023","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104859_bib78","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.stem.2020.05.008","article-title":"Metabolic reprograming via deletion of CISH in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity","volume":"27","author":"Zhu","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.critrevonc.2025.104859_bib79","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2021.06.013","article-title":"Targeting immunometabolism of neoplasms by interleukins: a promising i mmunotherapeutic strategy for cancer treatment","volume":"518","author":"Zhu","year":"2021","journal-title":"Cancer Lett."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825002471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:41:10Z","timestamp":1792986070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825002471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":79,"alternative-id":["S1040842825002471"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104859","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming of NK cells drives anti-tumor immunity","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104859"}}